Synageva BioPharma Corp.

Although the acquisitions of Celgene Corporation and Alexion Pharmaceuticals Inc. by Bristol Myers Squibb Company (BMS) and AstraZeneca PLC , respectively, were not given the best reception by

Less than a month after its first-quarter earnings release, Alexion Pharmaceuticals Inc. held a post-earnings corporate update call. For a stock that had until the update, significantly underperform

Two years ago the board of directors of Alexion Pharmaceuticals Inc. began a seismic overhaul of its leadership, strategy and pipeline. The Boston-based rare disease specialist had success with Soli

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Boehringer Ingelheim Taps In